In Asia Pacific, countries like China, Japan, and South Korea are witnessing a significant growth in the respiratory disease vaccine market. The rising healthcare expenditure, along with government initiatives to promote vaccination programs, is fueling the market growth in this region.
Europe, particularly the United Kingdom, Germany, and France, is also a lucrative market for respiratory disease vaccines. The high adoption rate of vaccines, along with a well-established healthcare infrastructure, is boosting the market growth in these countries.